Tvardi Therapeutics TVRD
NASDAQ TVRD
$1.24 -0.01 (-0.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Preferred Stock Liabilities (2013 - 2025)

Updated

Tvardi Therapeutics (TVRD) recorded Preferred Stock Liabilities of $85.5 million in Q1 2025, unchanged from $85.5 million a year earlier and unchanged from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Preferred Stock Liabilities (2013 - 2025) Analysis & Trends

Starting with Q1 2013, Tvardi Therapeutics' Preferred Stock Liabilities history includes 10 quarters.

  • Across earlier years, Preferred Stock Liabilities came in at $85.5 million in FY2023.
  • Per Business Quant, the preceding three quarters came in at $85.5 million (Q4 2024), $85.5 million (Q3 2024) and $85.5 million (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Tvardi Therapeutics 11.73 Mn 11.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 85.50 Mn
Dec 31, 2024 85.50 Mn
Sep 30, 2024 85.50 Mn
Jun 30, 2024 85.50 Mn
Mar 31, 2024 85.50 Mn
Dec 31, 2023 85.50 Mn
Dec 31, 2013 65.59 Mn
Sep 30, 2013 65.59 Mn
Jun 30, 2013 62.65 Mn
Mar 31, 2013 56.47 Mn
API Access

Tvardi Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=TVRD&period=max&api_key=YOUR_API_KEY